Skip to main content
. 2021 Aug 2;10(1):14–17. doi: 10.1016/j.jvsv.2021.07.009

Table.

Clinical details of each patient

Variable Patient 1 Patient 2 Patient 3
Hemoglobin, g/dL 14.8 16.9 12.7
Platelet count, per mm3 315 162 144
International normalized ratio 1.0 1.2 1.1
Troponin, ng/mL (normal <0.01 ng/mL) 0.28 0.46 NT
BNP, pg/mL 99 667 NT
D-dimer, μg/mL NT 10.61 NT
Pulmonary embolism Yes Yes No
RV TAPSE on echocardiogram 1.6 1 NT
RV/LV ratio 1.8 2.4 NT
Other thrombosis No DVT DVT
Symptom onset after vaccination, days 2 3 3
Initial anticoagulation treatment Heparin Enoxaparin Heparin
Discharge anticoagulation therapy Apixaban Rivaroxaban Apixaban

BNP, Brain natriuretic peptide; DVT, deep vein thrombosis; LV, left ventricle; NT, not tested; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion.